MYBPC3 gene therapy (Yes Pharmaceutical)

N/A

Report date: 2025/01/26 17:29:49

Base Information

Drug NameMYBPC3 gene therapy (Yes Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionMyosin-binding protein C, cardiac-type modulators
TargetsMyosin-binding protein C, cardiac-type
Therapy Area/IndicationsCardiomyopathy, Hypertrophic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYes Pharmaceutical Development Services Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesYes Pharmaceutical Development Services Gmbh
Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Hypertrophic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A